[EWTX] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[EWTX] Edgewise Therapeutics, Inc.
Announcement Date
11-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -17.79%
YoY- -36.13%
Quarter Report
EWTX's Result
EWTX's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 2,252 0 0 0 0 0 0 -
PBT -30,143 -25,713 -21,469 -22,838 -19,415 -17,498 -16,067 51.93%
Tax 3,604 -497 339 -3,107 -2,664 -764 -424 -
NP -30,143 -25,713 -21,469 -19,731 -16,751 -16,734 -15,643 54.66%
Tax Rate - - - - - - - -
Total Cost 32,395 25,713 21,469 19,731 16,751 16,734 15,643 62.25%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -1,338.50 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.47 -0.41 -0.34 -0.31 -0.26 -0.32 -0.32 29.12%
EPS Diluted -0.47 -0.41 -0.34 -0.31 -0.26 -0.32 -0.32 29.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.